Press Releases for AMAG

Press Releases
Analyst Choice Brings New Analysis on Level 3 Communications Inc., Arris Group Inc., Virgin Media Inc., The South Financial Group Inc., Wynn Resorts Limited and AMAG Pharmaceuticals Inc.
AMAG Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter Ended September 30, 2009
AMAG Pharmaceuticals, Inc. to Present at the Canaccord Adams 29th Annual Global Growth Conference
AMAG Pharmaceuticals, Inc. Reports Financial Results for the Quarter Ended June 30, 2009
AMAG Pharmaceuticals, Inc. to Host Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2009
AMAG Pharmaceuticals Announces U.S. Launch of Feraheme™ (ferumoxytol) Injection
FDA Approves Feraheme™ to Treat Iron Deficiency Anemia in Adult Chronic Kidney Disease Patients
FDA Decision on Feraheme NDA Expected Within Next Few Days
AMAG Pharmaceuticals, Inc. to Present at the Jefferies Third Annual Healthcare Conference
AMAG Pharmaceuticals Announces Appointment of Ricardo Zayas as Senior Vice President of Operations
AMAG Pharmaceuticals, Inc. to Present at the Eighth Annual Needham Life Sciences Conference
AMAG Pharmaceuticals, Inc. to Present at Deutsche Bank 34th Annual Healthcare Conference
AMAG Pharmaceuticals Announces New PDUFA Date for Feraheme™ (ferumoxytol injection)
AMAG Pharmaceuticals, Inc. Reports Financial Results for the Quarter Ended March 31, 2009
AMAG Pharmaceuticals, Inc. to Host Conference Call to Discuss Financial Results for the Quarter Ended March 31, 2009
Brian J.G. Pereira, MD, Receives 2009 David M. Hume Award
AMAG Pharmaceuticals, Inc. to Present at Citi’s 4th Annual Biotech Day
Zacks Analyst Blog Highlights: 3SBio Inc., AMAG Pharmaceuticals Inc., ANADIGICS, Inc., PetroChina Company Ltd., And Teekay Corporation - Mar 19 2009 11:53PM
AMAG Pharmaceuticals, Inc. to Present at the Cowen and Company 29th Annual Healthcare Conference
AMAG Pharmaceuticals, Inc. Reports Financial Results for the Quarter and Year Ended December 31, 2008
AMAG Pharmaceuticals, Inc. to Host Conference Call to Discuss Financial Results for the Quarter and Year Ended December 31, 2008
AMAG Pharmaceuticals, Inc. Announces Appointment of Robert J. Perez to Board of Directors
Zacks Bull & Bear of the Day Highlights: AMAG Pharmaceuticals, BJ Services, Logitech, Regions Financial and PetMed Express
AMAG Pharmaceuticals, Inc. to Present at the 27th Annual J.P. Morgan Healthcare Conference
AMAG Pharmaceuticals Receives Complete Response Letter from the FDA for Ferumoxytol
Zacks Analyst Blog Highlights: BJ's Wholesale Club, Inc., Stone EnergyCorp., NetEase.Com Inc., Nordstrom Inc. And 3SBio Inc.
AMAG Pharmaceuticals Announces Ferumoxytol Resubmission Designated Complete, Class 1 Response by the FDA
AMAG Pharmaceuticals, Inc. to Present at the Deutsche Bank 2008 Biotech Boston Confab
Zacks Bull and Bear of the Day Highlights: AMAG Pharmaceuticals, Overstock.Com, Humana, TC PipeLines and Smith Micro
AMAG Pharmaceuticals, Inc. Reports Financial Results for the Quarter Ended September 30, 2008
AMAG Pharmaceuticals, Inc. to Host Conference Call on November 3, 2008 to Discuss Financial Results for the Quarter Ended September 30, 2008
AMAG Pharmaceuticals Receives Complete Response Letter from FDA for Ferumoxytol
AMAG Pharmaceuticals, Inc. to Present at Two Upcoming Investor Conferences
AMAG Pharmaceuticals Receives Fast Track Designation for Ferumoxytol for Vascular-Enhanced Magnetic Resonance Imaging
AMAG Pharmaceuticals, Inc. to Present at the Canaccord Adams 28th Annual Global Growth Conference
AMAG Pharmaceuticals, Inc. Reports Financial Results for the Quarter Ended June 30, 2008
AMAG Pharmaceuticals, Inc. to Host Conference Call on July 29, 2008 to Discuss Financial Results for the Quarter Ended June 30, 2008
CORRECTING and REPLACING AMAG Pharmaceuticals, Inc. to Present at the Jefferies 2nd Annual Healthcare Conference
AMAG Pharmaceuticals, Inc. to Present at the Jefferies 2nd Annual Healthcare Conference
AMAG Pharmaceuticals, Inc. Announces Presentation of Positive Results from Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement Therapy in Kidney Transplant Recipients at the American Transplant Congress
AMAG Pharmaceuticals, Inc. to Webcast Upcoming Analyst and Investor Meeting
AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China - Business Wire
AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China - PR Newswire
AMAG Pharmaceuticals, Inc. Announces Appointment of Robert M. Brenner, M.D. as Senior Vice President of Medical Affairs - May 27 2008 12:57AM
AMAG Pharmaceuticals, Inc. to Present at the 2008 Citi Global Healthcare Conference - May 27 2008 12:52AM
AMAG Pharmaceuticals, Inc. Added to NASDAQ Biotech Index - Jun 1 2008 7:07AM
Semi-Annual Changes to the NASDAQ Biotechnology Index
AMAG Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference
AMAG Pharmaceuticals, Inc. Reports Financial Results for the Quarter Ended March 31, 2008
AMAG Pharmaceuticals, Inc. to Host Conference Call on April 25, 2008 to Discuss Financial Results for the Quarter Ended March 31, 2008
BellwetherReport.com Free Analyst Review for AMAG Pharmaceuticals, Spirit AeroSystems Holdings, Iomega Corp and Circuit City
AMAG Pharmaceuticals, Inc. to Present Additional Positive Results from Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement Therapeutic at National Kidney Foundation Spring Clinical Meetings